Evidence map›Paper›PMID 27604644›Full record

ReviewNature reviews. Disease primers2016

Otitis media.

Anne G M Schilder, Tasnee Chonmaitree, Allan W Cripps, Richard M Rosenfeld, Margaretha L Casselbrant, Mark P Haggard, Roderick P Venekamp

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Disease primers, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 286 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
286citing papers in PubMed, 14 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

286 citing papers in PubMed, 14 syntheses or guidelines pooled it, 554 citations in OpenAlex.

  1. Decongestants and antihistamines for acute otitis media in children.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Systemic antibiotics for chronic suppurative otitis media.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Topical versus systemic antibiotics for chronic suppurative otitis media.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Antibiotics versus topical antiseptics for chronic suppurative otitis media.The Cochrane database of systematic reviews · 2025
    Pooled it
  5. Aural toilet (ear cleaning) for chronic suppurative otitis media.The Cochrane database of systematic reviews · 2025
    Pooled it
  6. Topical antiseptics for chronic suppurative otitis media.The Cochrane database of systematic reviews · 2025
    Pooled it
  7. Topical antibiotics with steroids for chronic suppurative otitis media.The Cochrane database of systematic reviews · 2025
    Pooled it
  8. Topical antibiotics for chronic suppurative otitis media.The Cochrane database of systematic reviews · 2025
    Pooled it
  9. A Systematic Review and Meta-Analysis of the Efficacy of Antimicrobial Chemoprophylaxis for Recurrent Acute Otitis Media in Children.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2025
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Adenoidectomy for otitis media with effusion (OME) in children.The Cochrane database of systematic reviews · 2023
    Pooled it
  14. Dysregulation of immune response in otitis media.Expert reviews in molecular medicine · 2021
    Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Observational
  20. Article

226 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 4 countries.

Anne G M SchilderevidENT, Ear Institute, University College London, Royal National Throat Nose and Ear Hospital, 330 Grays Inn Road, WC1X 8DA London, UK.
Tasnee ChonmaitreeDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Texas Medical Branch, Galveston, Texas, USA.
Allan W CrippsSchool of Medicine and Menzies Health Institute Queensland, Griffith University, Queensland, Australia.
Richard M RosenfeldDepartment of Otolaryngology, SUNY Downstate Medical Center, Brooklyn, New York, USA.
Margaretha L CasselbrantUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Mark P HaggardDepartment of Psychology, University of Cambridge, Cambridge, UK.
Roderick P VenekampJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
University Medical Center Utrecht · NLGriffith University · AUSUNY Downstate Health Sciences University · USThe University of Texas Medical Branch at Galveston · USUniversity of Cambridge · GBUniversity of Pittsburgh · US

Funding

UTMB Clinical and Translational Science AwardUL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI URBAN, RANDALL J · 2015 to 2024
$40.0M
Pathogenesis of Virus-Induced Acute Otitis MediaR01DC005841 · NIDCD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CHONMAITREE, TASNEE · 2002 to 2013
$5.9M
Department of Health NIHR-RP-011-045NCATS NIH HHS UL1 TR001439NIDCD NIH HHS R01 DC005841
6 · The paper itself

Abstract

Otitis media (OM) or middle ear inflammation is a spectrum of diseases, including acute otitis media (AOM), otitis media with effusion (OME; 'glue ear') and chronic suppurative otitis media (CSOM). OM is among the most common diseases in young children worldwide. Although OM may resolve spontaneously without complications, it can be associated with hearing loss and life-long sequelae. In developing countries, CSOM is a leading cause of hearing loss. OM can be of bacterial or viral origin; during 'colds', viruses can ascend through the Eustachian tube to the middle ear and pave the way for bacterial otopathogens that reside in the nasopharynx. Diagnosis depends on typical signs and symptoms, such as acute ear pain and bulging of the tympanic membrane (eardrum) for AOM and hearing loss for OME; diagnostic modalities include (pneumatic) otoscopy, tympanometry and audiometry. Symptomatic management of ear pain and fever is the mainstay of AOM treatment, reserving antibiotics for children with severe, persistent or recurrent infections. Management of OME largely consists of watchful waiting, with ventilation (tympanostomy) tubes primarily for children with chronic effusions and hearing loss, developmental delays or learning difficulties. The role of hearing aids to alleviate symptoms of hearing loss in the management of OME needs further study. Insertion of ventilation tubes and adenoidectomy are common operations for recurrent AOM to prevent recurrences, but their effectiveness is still debated. Despite reports of a decline in the incidence of OM over the past decade, attributed to the implementation of clinical guidelines that promote accurate diagnosis and judicious use of antibiotics and to pneumococcal conjugate vaccination, OM continues to be a leading cause for medical consultation, antibiotic prescription and surgery in high-income countries.

Indexed as

Hearing LossHumansMiddle Ear VentilationOtitis MediaOtoscopyPainQuinolonesRisk FactorsTympanic MembraneQuinolones

Identifiers

PMID27604644
PMCPMC7097351
OpenAlexW4211248544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.